drugset / Trial / NCT04534491

Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.

NCT04534491

Phase 3 Completed 855 enrolled Bayer
NaSingle-groupOpen-labelTreatment

Summary

With this study researchers want to gather information about the consumer use behavior of Oxytrol in a simulated setting in which the medicine is sold directly to a consumer without a prescription from a healthcare professional. An area of focus was on the potential benefits of an over-the-counter status for Oxytrol and on the ongoing use behavior of the consumers. Oxytrol is a thin, flexible, clear patch that is indicated for the treatment of overactive bladder a disease characterized by a collection of symptoms, including urinary frequency, urgency, and urge incontinence. The adhesive patch is placed on the skin to deliver Oxytrol through the skin into the bloodstream.

Timeline

Start
2010-05-25
Primary completion
2011-06-22
Completion
2011-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxybutynin Small molecule 3.9 mg Other

Indications